B. Riley Wealth Advisors’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-229,200
| Closed | -$493K | – | 1291 |
|
2024
Q2 | $493K | Buy |
229,200
+180,050
| +366% | +$387K | 0.01% | 826 |
|
2024
Q1 | $83.6K | Sell |
49,150
-114,200
| -70% | -$194K | ﹤0.01% | 1371 |
|
2023
Q4 | $374K | Buy |
163,350
+114,200
| +232% | +$262K | 0.01% | 957 |
|
2023
Q3 | $83.6K | Buy |
49,150
+4,205
| +9% | +$7.15K | ﹤0.01% | 1371 |
|
2023
Q2 | $111K | Buy |
44,945
+9,295
| +26% | +$23K | ﹤0.01% | 1423 |
|
2023
Q1 | $80.2K | Buy |
35,650
+16,500
| +86% | +$37.1K | ﹤0.01% | 1406 |
|
2022
Q4 | $97.9K | Buy |
19,150
+3,500
| +22% | +$17.9K | ﹤0.01% | 1361 |
|
2022
Q3 | $163K | Buy |
15,650
+5,400
| +53% | +$56.2K | ﹤0.01% | 1264 |
|
2022
Q2 | $106K | Buy |
10,250
+560
| +6% | +$5.79K | ﹤0.01% | 1115 |
|
2022
Q1 | $172K | Buy |
9,690
+40
| +0.4% | +$710 | 0.01% | 1235 |
|
2021
Q4 | $301K | Sell |
9,650
-2,250
| -19% | -$70.2K | 0.01% | 1072 |
|
2021
Q3 | $393K | Buy |
11,900
+300
| +3% | +$9.91K | 0.01% | 900 |
|
2021
Q2 | $343K | Buy |
11,600
+2,500
| +27% | +$73.9K | 0.01% | 951 |
|
2021
Q1 | $286K | Buy |
9,100
+5,550
| +156% | +$174K | 0.01% | 1027 |
|
2020
Q4 | $95K | Buy |
3,550
+600
| +20% | +$16.1K | 0.01% | 991 |
|
2020
Q3 | $80K | Buy |
+2,950
| New | +$80K | ﹤0.01% | 904 |
|